These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22015691)

  • 21. Aspirin-triggered proresolving mediators stimulate resolution in cancer.
    Gilligan MM; Gartung A; Sulciner ML; Norris PC; Sukhatme VP; Bielenberg DR; Huang S; Kieran MW; Serhan CN; Panigrahy D
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6292-6297. PubMed ID: 30862734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory mechanism of omega-3 fatty acids in pancreatic inflammation and apoptosis.
    Park KS; Lim JW; Kim H
    Ann N Y Acad Sci; 2009 Aug; 1171():421-7. PubMed ID: 19723085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation.
    Kure I; Nishiumi S; Nishitani Y; Tanoue T; Ishida T; Mizuno M; Fujita T; Kutsumi H; Arita M; Azuma T; Yoshida M
    J Pharmacol Exp Ther; 2010 Feb; 332(2):541-8. PubMed ID: 19846590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoxins: endogenous regulators of inflammation.
    McMahon B; Godson C
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F189-201. PubMed ID: 14707005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
    Petasis NA; Akritopoulou-Zanze I; Fokin VV; Bernasconi G; Keledjian R; Yang R; Uddin J; Nagulapalli KC; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):301-21. PubMed ID: 16098719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The roles of special proresolving mediators in pain relief.
    Zhang LY; Jia MR; Sun T
    Rev Neurosci; 2018 Aug; 29(6):645-660. PubMed ID: 29420307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary omega-3 fatty acids: effects on lipid mediators of inflammation and rheumatoid arthritis.
    Sperling RI
    Rheum Dis Clin North Am; 1991 May; 17(2):373-89. PubMed ID: 1862246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation?
    Bonnans C; Chanez P; Chavis C
    Allergy; 2004 Oct; 59(10):1027-41. PubMed ID: 15355460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
    Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C
    Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoxin Mimetics and the Resolution of Inflammation.
    Godson C; Guiry P; Brennan E
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():429-448. PubMed ID: 36662584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.
    Spite M; Serhan CN
    Circ Res; 2010 Nov; 107(10):1170-84. PubMed ID: 21071715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is multiple sclerosis a proresolution deficiency disorder?
    Das UN
    Nutrition; 2012 Oct; 28(10):951-8. PubMed ID: 22521616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoxins: pro-resolution lipid mediators in intestinal inflammation.
    Goh J; Godson C; Brady HR; Macmathuna P
    Gastroenterology; 2003 Apr; 124(4):1043-54. PubMed ID: 12671901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators.
    Norling LV; Ly L; Dalli J
    Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):145-152. PubMed ID: 28002074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
    Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into eicosanoid biosynthetic pathways: implications for arthritis.
    Kojima F; Kapoor M; Kawai S; Crofford LJ
    Expert Rev Clin Immunol; 2006 Mar; 2(2):277-91. PubMed ID: 20477078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between the fatty acid composition of immune cells and their function.
    Calder PC
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):101-8. PubMed ID: 18951005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid mediator networks and leukocyte transmigration.
    Louis NA; Hamilton KE; Colgan SP
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):197-202. PubMed ID: 15979294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoxins: update and impact of endogenous pro-resolution lipid mediators.
    O'Meara SJ; Rodgers K; Godson C
    Rev Physiol Biochem Pharmacol; 2008; 160():47-70. PubMed ID: 18481030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoxins: resolutionary road.
    Maderna P; Godson C
    Br J Pharmacol; 2009 Oct; 158(4):947-59. PubMed ID: 19785661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.